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Implications of Underlying Pathophysiology of Osteomyelitis in Diabetics for Nursing Care
Danielle Spencer, BSN, RN
Otterbein University, Westerville, Ohio
Pathophysiological Processes

Introduction
Osteomyelitis is an infection of the bone
caused by either bacteria, fungi,
parasites, viruses or mycobacteria
(McCance, et. al., 2014). The infection
can enter bone either through an outside
source or through the blood from a blood
borne infection (McCance, et. al., 2014).
The most common bacteria involved with
osteomyelitis is Staphylococcus aureus
(Hatzenbuehler & Pulling, 2011, p. 1027).
Recently, at Dublin Methodist Hospital
there has been an increase in the number
of osteomyelitis cases in chronic
uncontrolled diabetic patients requiring
below the knee amputations. Two of the
cases specifically were linked to chronic
diabetic foot ulcers. Each of these cases
were only planned to be partial foot
amputations but resulted in below the
knee amputations causing much stress
for the patients and families. Diabetics
are highly susceptible to diabetic foot
ulcers and subsequent infections for two
reasons. The first reason is that they
have peripheral neuropathy and thus
may not be able to feel a trauma to their
foot or limb; and, secondly, because they
have peripheral vascular disease limiting
blood flow and thus healing to a wound
site (Hatzenbuehler & Pulling, 2011, p.
1028). The pathophysiology of
osteomyelitis is linked to bone
degeneration and often the infection
itself can be prevented with adequate
and proactive nursing care. New ways to
diagnosis and treat osteomyelitis are
being explored through new research as
will be examined in this research poster.
Implications for better patient care and
prevention will be obtained through
gathering of the research
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Because osteomyelitis is an infection
of the bone, a precursor infection
must occur in which the pathogenic
bacteria transfer from a soft tissue
injury to the bone in closest
proximity.
The preceding symptoms of infection
would be the same as any infection
including warm, redness and
tenderness at the site. At times,
fever accompanies infection.
Hatzenbuehler and colleagues from
the American Academy of Family
Physicians state that symptoms of
osteomyelitis itself may not present
for approximately two weeks after
the invading pathogens get to the
bone (Hatzenbuehler & Pulling, 2011,
p. 1027).
It is stated that necrotic bone from
osteomyelitis may not occur for six
weeks after onset of infection
(Hatzenbuehler & Pulling, 2011, p.
1027).
“Clinical symptoms include chronic
pain, persistent sinus tract or wound
drainage, poor wound healing, and
sometimes fever” (Hatzenbuehler &
Pulling, 2011, p. 1028).
Osteomyelitis is also often associated
with diabetes and peripheral
vascular disease. These two
conditions make a person more
susceptible to wounds of the
extremities because of neuropathy,
unawareness of a wound and
decreased blood flow resulting in
poor wound healing and ultimately
the opportunity for further infection.
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Implications for
Nursing Care

Underlying
Pathophysiology
The pathophysiology of osteomyelitis
starts with some sort of insult to the
bone whether that be hematologic in
origin or from a proximal wound of a
diabetic ulcer. The original insult will
spreads to the deeper structures and
finally to the bone (Malone, Gannass, et.
al. 2013, p. 318). Staphylococcus aureus
is the most common invading pathogen
that causes osteomyelitis. As with any
other infections, the pathological
process with osteomyelitis includes
“synthesis of proinflammatory cytokines,
activation and mobilization of phagocytic
cells, thrombosis, [and] necrosis” and in
osteomyelitis specifically: “bone
sequestration, and formation of new
bone” occur (Grbic, et. al., 2014, p. 1).
S. aureus is capable of interacting with
osteoblasts, bone-forming agents in
bones, to alter bone reabsorption
(Cassat, et. al., 2013). One mechanism
that occurs is that S. aureus causes
osteoclastogenesis, or the production of
osteoclasts which are bone-reabsorbing
cells through the expression of
proinflammatory cytokines and the
osteoclast-activator molecule receptor
system (RANK-L) (Cassat, et. al., 2013, p.
759). And secondly, the invasion of S.
aureus-infected osteoclasts causes cell
death (Cassat, et. al., 2013, p. 760).
Cassat and colleagues who explored the
pathophysiology of osteomyelitis in
depth state that “pathogen-induced
bone destruction…destroys the vascular
architecture of the infected bone and
limits antimicrobial penetration to the
infectious focus (Cassat, et. al., 2013, p.
766). Furthermore, Cassat and
colleagues summarize their findings by
stating that “S. aureus induces profound
changes in bone remodeling, in part
through the production of osteolytic
exoproteins that modulate osteoblast
proliferation…suggesting that bacterial
modulation of bone remodeling involves
complex changes in bone physiology”
(Cassat, et. al., 2013, p. 766). Finally,
damage is done to the bone in
osteomyelitis by the oxidative stress that
is produced by highly reactive oxidants
of the leukocytes that move to the site
of infection. Oxidative stress has been
found to increase osteoclast activity and
suppress the maturation of osteoblasts
further increasing harmful bone
remodeling (Grbic, et. al., 2014, p. 1).
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Significance of Pathophysiology
The significance of the pathophysiology of osteomyelitis lies in the implications that the
infectious process has for treatment, diagnosis and nursing and medical care. Treatment of
osteomyelitis is complicated by the pathogen-induced bone destruction and remodeling and
therapies should target limiting the bone destruction that does occur (Cassat, et. al., 2013, p.
766). Cassat and colleagues at the Vanderbilt University Health System developed a bone
model to support the theory that therapy needs to be targeted at bone physiology rather
that only at antibiotic treatment with immune therapies that limit pathologic bone
remodeling during osteomyelitis (Cassat, et. al., 2013, p. 768). This produces significant
implications for treatment preferences and options. The preferred method of treatment for
osteomyelitis is long term intravenous antibiotics. The appropriate antibiotic to use is
determined by results of wound or bone cultures and biopsies (Hatzenbuehler & Pulling,
2011, p. 1031). Intravenous therapy should continue for two to six weeks with a transition to
oral antibiotics (Hatzenbuehler & Pulling, 2011, p. 1032). It has been found that intravenous
vancomycin is the first drug of choice for treatment of osteomyelitis (Hatzenbuehler &
Pulling, 2011, p. 1032). Furthermore, since the pathophysiology of osteomyelitis does
involve altered bone remodeling the gold standard in diagnosis has been bone biopsies
(Malone, Bowling, et. al, 2013, p. 547). Bone biopsies, though, are expensive and painful for
patients so other alternatives for diagnosis need to be found based on the pathophysiology
discovered (Malone, Bowling, et. al, 2013, p. 547). Malone and colleagues found that “deep
wound cultures correlate well with osseous cultures and provide a sensitive method in
assessing and targeting likely pathogens that cause osseous infections. This will help aid the
clinician in guiding antibiotic therapy” (Malone, Bowling, et. al, 2013, p. 546). The wound
cultures that they used were specifically from deep wounds or taken from in wound sinus
tracts (Malone, Bowling, et. al, 2013, p. 549). Another diagnostic tool that relates to the
pathophysiology of osteomyelitis and inflammation is the increase in inflammatory markers
that can be found on diagnostic lab work. A study that examined the levels of inflammatory
markers C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cells
(WBC), and procalcitonin (PCT) in osteomyelitis compared to soft tissue injuries found that all
inflammatory markers were significantly higher in osteomyelitis (Michail, et. al., 2013, p. 96).
Furthermore, the study found that ESR was actually the best marker to monitor the response
to therapy (Michail, et. al., 2013, p. 96). Surgical intervention may be needed in some cases
due to failure to respond to antibiotics, infected surgical hardware and chronic osteomyelitis
with necrotic bone (Hatzenbuehler & Pulling, 2011, p. 1032).

•

Diabetes and osteomyelitis clearly
coincide so special attention needs
to be pain to diabetics with chronic
ulcers and peripheral vascular
disease
Not only do diabetic patients have
peripheral neuropathy leading to an
increased risk of not recognizing a
wound advancing into an infection,
but they also have “microvascular
abnormalities and phagocytosis
defects” which “are likely to facilitate
the spread of bacterial infection
throughout the medulla and cortical
bones” (Senneville, et. al., 2012, p.
59).
Poor glycemic control leads to the
complications of diabetes that are
linked to osteomyelitis so better
glycemic control can limit these
complications and risk factors. It can
be implied that nurses can take an
active role in diabetic education that
will truly make a difference in patient
outcomes in preventing
osteomyelitis and limiting
complications from osteomyelitis.
Furthermore, nurses can educate
about other aspects of diabetes
management such as good foot care,
need for routine follow-up and
getting healthcare in a timely
manner (Malone, Gannass, et. al.
2013, p. 323).

Conclusions
Osteomyelitis can be difficult to
diagnose and treat so clinicians must be
aware of the special care that these
patients require (Lipsky, et. al., 2012, p.
1679). Treatment and diagnosis need to
be based on current knowledge of the
pathophysiology of osteomyelitis and
targeted specifically towards that. Special
nursing care and education can be given to
diabetic patients at risk for developing
osteomyelitis to maintain adequate
glycemic control. These patients also
require specific follow up after suffering
from osteomyelitis to be sure that it does
not reoccur including good wound care, a
completed antibiotic therapy course and
follow ups with specialist. A
multidisciplinary foot team can help
improve patient and hospital outcomes
(Lipsky, et. al., 2012, p. 1679).
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